retatrutide triple hormone receptor agonist mechanism of action Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Retatrutide: breakthrough… or still too

The information provided shouldn't be used to diagnose or treat any medical condition

This aligns with our commitment to enhancing patient wellness and aesthetic satisfaction through innovative and personalized care

This conversation is particularly important for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2), as these represent absolute contraindications to the use of products with the thyroid C-cell tumor boxed warning, including semaglutide, liraglutide, dulaglutide, exenatide extended-release, and tirzepatide

Front Pharmacol (2020) 11:356

J Ethnopharmacol 2003;87:115-7

Elevated insulin levels also tell your ovaries to produce more testosterone, which can disrupt ovulation, throw off your cycle, and make it harder to get pregnant